E-LIB Suche - Ergebnisse für: Löfstedt, Ernst

1

Pharmaceutical Benefit-Risk Perception and Older Age: A Pil..:

Balog-Way, Dominic Hugo Patrick ; Löfstedt, Ragnar Ernst
Therapeutic Innovation & Regulatory Science. 54 (2020) 3 - p. 645-657 , 2020

Link: https://doi.org/10.1007/..

2

Pharmaceutical Benefit-Risk Perception and Older Age: A Pil..:

Balog-Way, Dominic Hugo Patrick ; Löfstedt, Ragnar Ernst
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

3

Pharmaceutical Benefit-Risk Perception and Older Age:A Pilo..:

Balog-Way, Dominic ; Lofstedt, Ragnar Ernst Vilhelm
Balog-Way , D & Lofstedt , R E V 2019 , ' Pharmaceutical Benefit-Risk Perception and Older Age : A Pilot Study ' , Therapeutic innovation & regulatory science .. , 2019

Link: https://kclpure.kcl.ac.u..

4

Evidence based uncertainty analysis: What should we now do ..:

Lofstedt, Ragnar Ernst Vilhelm ; Bouder, Frederic
Lofstedt , R E V & Bouder , F 2017 , ' Evidence based uncertainty analysis: What should we now do in Europe? A view point ' , Journal of Risk Research . https://doi.org/10.1080/13669877.2017.1316763. , 2017

Link: https://kclpure.kcl.ac.u..

5

Evidence based uncertainty analysis: What should we now do ..:

Lofstedt, Ragnar Ernst Vilhelm ; Bouder, Frederic
Lofstedt , R E V & Bouder , F 2017 , ' Evidence based uncertainty analysis: What should we now do in Europe? A view point ' , Journal of Risk Research . https://doi.org/10.1080/13669877.2017.1316763. , 2017

Link: https://kclpure.kcl.ac.u..

6

Nuclear Accidents and Policy Responses in Europe:Comparing ..:

Krieger, Kristian ; Renn, Ortwin ; Rogers, Marian Brooke.
Krieger , K , Renn , O , Rogers , M B & Lofstedt , R E V 2017 , Nuclear Accidents and Policy Responses in Europe : Comparing the Cases of France and Germany . in E Balleisen , L Bennear , K Krawiec & J Wiener (eds) , Policy Shock : Recalibrating Risk and Regulation after Oil Spills, Nuclear Accidents, and Financial Crisis . pp. 245-268 . https://doi.org/doi:10.1017/9781316492635.011. , 2017

Link: https://kclpure.kcl.ac.u..

7

Medicines transparency at the European Medicines Agency (EM..:

Balog-Way, Dominic ; Bouder, Frederic ; Lofstedt, Ragnar Ernst Vilhelm.
Balog-Way , D , Bouder , F , Lofstedt , R E V & Evensen , D 2016 , ' Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients ' , Journal of Risk Research , pp. 1-31 . https://doi.org/10.1080/13669877.2016.1200652. , 2016

Link: https://kclpure.kcl.ac.u..

8

Medicines transparency at the European Medicines Agency (EM..:

Balog-Way, Dominic ; Bouder, Frederic ; Lofstedt, Ragnar Ernst Vilhelm.
Balog-Way , D , Bouder , F , Lofstedt , R E V & Evensen , D 2016 , ' Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients ' , Journal of Risk Research , pp. 1-31 . https://doi.org/10.1080/13669877.2016.1200652. , 2016

Link: https://kclpure.kcl.ac.u..

9